• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON LABORATORIES IRELAND LTD. CLAREON TORIC ASPHERIC HYDROPHOBIC ACRYLIC IOL WITH AUTONOME DELIVERY SYSTEM; LENS, INTRAOCULAR, TORIC OPTICS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON LABORATORIES IRELAND LTD. CLAREON TORIC ASPHERIC HYDROPHOBIC ACRYLIC IOL WITH AUTONOME DELIVERY SYSTEM; LENS, INTRAOCULAR, TORIC OPTICS Back to Search Results
Model Number CNA0T3
Medical Device Problem Code Material Deformation (2976)
Health Effect - Clinical Code Insufficient Information (4580)
Date of Event 02/27/2026
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The product was not returned for analysis; the lens remains implanted.Complaint history and product history record could not be reviewed because the reporting facility did not provide a valid lot number or any identification traceable to the manufacturing documentation.Root cause has not been identified.Photo review: this photograph is of an iol (intraocular lens) through an undilated pupil.There is a mild opacity of uniform density on the majority of the lens within the capsulorhexis.The density is such that is seems unlikely to affect vision in a significant manner.The above findings likely demonstrate lens subsurface nanoglistening (ssng).Ssngs are caused by a phase separation of water (from the aqueous humor) on the iol subsurface, whereas glistenings are attributed to water phase separation within the matrix of the hydrated iol material.The manufacturer internal reference number is: (b)(4).
 
Event or Problem Description
A health care professional reported that following an intraocular lens (iol) implant procedure, surgeon felt there was a film or sub surface nano glistenings on lens on consult two years after lens implant.Additional information has been requested and received stating that the lens was not explanted and there was no plan to explant the lens.
 
Additional Manufacturer Narrative
A product history record review and a non-conformance review of the reported lot number was conducted.No deviations were identified and all corresponding production release specifications defined in the device master record were met.Based on our observation of the attached photo, the reported issue most likely demonstrates lens subsurface nanoglistening (ssng).The root cause for the reported complaint could not be determined based on the returned photos.A definitive determination of the reported complaint cannot be made without the evaluation of the physical product.No sample was returned for analysis.Based on the results from the product history record, the products met release criteria.The manufacturer internal reference number is: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLAREON TORIC ASPHERIC HYDROPHOBIC ACRYLIC IOL WITH AUTONOME DELIVERY SYSTEM
Common Device Name
LENS, INTRAOCULAR, TORIC OPTICS
Manufacturer (Section D)
ALCON LABORATORIES IRELAND LTD.
cork business&technology park
model farm road
cork 00000
EI  00000
Manufacturer (Section G)
ALCON LABORATORIES IRELAND LTD.
cork business&technology park
model farm road
cork 00000
EI   00000
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8007579780
MDR Report Key24717353
Report Number9612169-2026-00679
Device Sequence Number20363864
Product Code MJP
UDI-Device Identifier00380652398893
UDI-Public(01)00380652398893(17)280302(11)240304(10)25803764
Combination Product (Y/N)N
Initial Reporter CountryAS
PMA/510(K) Number
P190018
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,User Facility,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 04/23/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberCNA0T3
Device Lot Number25803764
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 03/04/2026
Supplement Date Received by Manufacturer03/30/2026
Initial Report FDA Received Date03/30/2026
Supplement Report FDA Received Date04/23/2026
Date Device Manufactured03/04/2024
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
PROVISC OVD
Patient Age64 YR
Patient SexFemale
-
-